We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
+$16.3M
Cap. Flow
-$44.8M
Cap. Flow %
-2.69%
Top 10 Hldgs %
48.94%
Holding
82
New
33
Increased
12
Reduced
12
Closed
25

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$73.8M
2
VTRS icon
Viatris
VTRS
+$64.3M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$63M
4
MRK icon
Merck
MRK
+$56.2M
5
ENDP
Endo International plc
ENDP
+$53.9M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$95.6M
2
AGN
Allergan Inc
AGN
+$94.5M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$68.8M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$50.3M
5
MJN
Mead Johnson Nutrition Company
MJN
+$50.3M

Sector Composition

Rank Sector Weight
1 Healthcare 65.49%
2 Financials 4.97%
3 Technology 1.5%
4 Consumer Staples 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
$151M 9.11%
8,400,000
-1,600,000
-16% -$27.7M
VTRS icon
2
Viatris
VTRS
$20.7B
$100M 6.02%
2,050,000
+1,325,000
+183% +$64.3M
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
$96.3M 5.79%
3,100,000
+50,000
+2% +$1.58M
EHTH icon
4
eHealth
EHTH
$43.8M
$82.5M 4.97%
1,625,000
-75,000
-4% -$3.91M
SLXP
5
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$67.3M 4.05%
650,000
+250,000
+63% +$25.6M
MRK icon
6
Merck
MRK
$321B
$65.3M 3.93%
1,205,200
+1,085,623
+908% +$56.2M
MDVN
7
DELISTED
MEDIVATION, INC.
MDVN
$64.4M 3.87%
+2,000,000
New +$73.8M
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$63.4M 3.81%
+1,000,000
New +$63M
MCK icon
9
McKesson
MCK
$101B
$61.8M 3.72%
350,000
-250,000
-42% -$43.7M
GILD icon
10
Gilead Sciences
GILD
$163B
$61M 3.67%
860,492
+685,492
+392% +$53.8M
CBST
11
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$53M 3.19%
725,000
-675,000
-48% -$50.3M
ISRG icon
12
CALL
Intuitive Surgical
ISRG
$126B
$52.6M 3.16%
+1,080,000
New +$50.9M
ENDP
13
DELISTED
Endo International plc
ENDP
$52.2M 3.14%
+760,100
New +$53.9M
WBMD
14
DELISTED
WebMD Health Corp.
WBMD
$51.8M 3.11%
1,250,000
+100,000
+9% +$4.51M
MRK icon
15
CALL
Merck
MRK
$321B
$42.6M 2.56%
+786,000
New +$40.7M
TSRO
16
DELISTED
TESARO, Inc.
TSRO
$41.3M 2.48%
+1,400,000
New +$44.1M
CFN
17
DELISTED
CAREFUSION CORPORATION
CFN
$40.2M 2.42%
+1,000,000
New +$40.5M
A icon
18
Agilent Technologies
A
$39.2B
$39.1M 2.35%
978,600
+104,850
+12% +$4.32M
NUVA
19
DELISTED
NuVasive, Inc.
NUVA
$38.4M 2.31%
1,000,000
+225,000
+29% +$8.27M
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
$32.9M 1.98%
475,000
+376,437
+382% +$27.6M
MYGN icon
21
Myriad Genetics
MYGN
$507M
$29.2M 1.76%
854,900
+204,900
+32% +$6.35M
CTRX
22
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$28M 1.68%
+625,000
New +$30.1M
NUAN
23
DELISTED
Nuance Communications, Inc.
NUAN
$24.9M 1.5%
+1,674,750
New +$22.5M
INCY icon
24
PUT
Incyte
INCY
$24.9B
$24.1M 1.45%
+450,000
New +$27.9M
SGEN
25
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$22.8M 1.37%
+500,000
New +$23.9M
1
2 3 4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2014 Portfolio in Review

As of Q1 2014, HealthCor Management held 82 positions worth $1.66B, up 0.99% from $1.65B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HealthCor Management's Q1 2014 filing shows 33 new, 12 increased, 12 reduced and 25 closed positions. Its largest new stake was MEDIVATION, INC.: 2,000,000 shares worth $64.4M. The largest sale was ARTHROCARE CORP, an estimated $95.6M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 60% a quarter earlier, followed by Financials and Technology.

  • HealthCor Management's largest Q1 2014 buy was MEDIVATION, INC.: 2,000,000 shares worth $64.4M.
  • HealthCor Management added most to Viatris in Q1 2014, an estimated $64.3M increase.
  • HealthCor Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $94.5M.
  • HealthCor Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $95.6M.
  • HealthCor Management's ten largest holdings make up 49% of its $1.66B portfolio in Q1 2014.
  • HealthCor Management opened 33 new positions and closed 25 in Q1 2014.
  • HealthCor Management's portfolio value rose 0.99% quarter-over-quarter to $1.66B.

Based on HealthCor Management's 13F filing for Q1 2014, filed 15 May 2014.